Our ITO™ platform integrates wet lab, computational, and proxy data to help companies reliably drug the undruggable.
Source-reported As recorded 2026-09-23
Browser storage is unavailable. Keep this page open and export your collection before leaving.
Biotech pharma
1910
Overview
We are the only AI-native biotech pioneering small and large molecule therapeutics discovery by integrating massive multimodal data, frontier AI models, and high-throughput lab automation into an infrastructure for AI-enabled drug discovery.
Company description As recorded 2026-11-08
Product & workflow
Founders & team
Previously 1910 Genetics
Company history As recorded 2026-11-08
Jen Asher
Founder/CEOFounder & CEO @ 1910 Genetics
Founder profile As recorded 2026-09-15
20team members reported
Source-reported As recorded 2026-09-15
Founded 2018 · Source
News & product activity
Cohort membership
Winter 2019Winter 2019
Original evidence ↗Sources & observations
Profile depthverified profile
Website observationwebsite reachable
Last website check2026-11-11
Location · source statedBoston, MA, USA
Pricing evidenceNo pricing page confirmed
Maturity: Not assessed · 3 of 6 areas documented
Source-based assessment · automated evidence rules
The retained text does not establish product availability or customer use.
Maturity is an evidence-based assessment, not a success rating. It may understate the current stage where evidence is limited. Coverage records documented areas, not a complete or independently audited company history.
- Product overviewSource description Checked 2026-11-08
- Product visualsNot documented
- Founders & originsTeam information
- Business model & pricingNot documented
- Funding & ownershipNot documented
- Dated milestonesDated source activity: 2019 Q1 (quarter only)
independent websitesource corroborationreachable websitedescriptive evidenceclassified market and modelsourced peoplesourced founding year
Similar businesses
Anthrogen is engineering post-modality biology. Today's modalities reflect historical contingencies in biological progress, not fundamental categories. We develop the AI systems that design modular biological machines and the…
Founders · Product
- Founded
- 2024
- Team
- 15 people
Same product type · Infrastructure
Anto is building a foundation model for microbial communities, making the gut microbiome computable for the first time. We predict drug toxicity and efficacy across diverse populations and fix drugs so they work for everyone — solving…
Founders · Product
- Founded
- 2025
- Team
- 4 people
Same product type · Infrastructure
BioStack is building the data engine for healthcare and drug discovery AI. The bottleneck is not models. It is access to high-quality biological data. Clinical and experimental data is fragmented, unstructured, and locked inside…
Founders · Product
- Founded
- 2025
- Team
- 9 people
Same product type · Infrastructure
Transform scattered lab data into structured insights. Labric automatically captures instrument data, enables AI-powered analysis, and saves research teams hundreds of hours.
Founders · Product · How it works
- Founded
- 2025
- Team
- 6 people
Same product type · Infrastructure
What if we made as many cancer drugs next year as we have in the last decade?
Founders · Product
- Founded
- 2025
- Team
- 4 people
Same product type · Infrastructure
Spatial proteomics from H&E and multimodal patient data imputation. Lattice predicts spatially resolved protein-marker maps from routine H&E slides as virtual multiplex immunofluorescence (mIF) channels, transforming incomplete patient…
Founders · Product · How it works
- Founded
- 2025
- Team
- 2 people
Same product type · Infrastructure